100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients80% CR and 90% Composite Complete Remissions (CCR); median OS not reached after 9 months and good tolerability70% of patients derived to Hematopoietic Stem Cell Transplantation (HSCT) 67% CCR at the expansion dose in study evaluating iadademstat plus gilterinib in FLT3-mutated relapsed/refractory AML patients; 47% CR+CRhTreatment was safe and well tolerated MADRID, SPAIN and CAMBRIDGE, Mass. ...

VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce it has received positive results from the 2025 Exploration Program (the “Program”) at its Penny Copper Project (the “Project” or the “Property”). The Project is strategically located in the Fort Steele Mining Division near the Sullivan Mine in Kimberley, British Columbia. 2025 Exploration Program Summary Airborne Mobile Magnetotelluric (“MobileMT”) Survey ...

LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, announces financial results for the fiscal year ended 30 September 2025. Consistent with management’s preliminary assessment of the expected range of revenue which was announced 9 October 2025, reported revenue for the fiscal year ended 30 September 2025 was $530,000.Revenue for the second half of the fiscal year was $463,000 as compared to $67,000 for the first ...

Billings, Montana, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced fertilizers produced from manure and other organic waste, announced they have executed a Memorandum of Understanding with Kimmeridge Energy Management Company, LLC, an alternative asset manager focused on the energy sector. The MOU outlines a preliminary framework to explore the use of Bion’s ammonia recovery technology at a large Renewable Natural Gas (RNG) facility. Under the MOU ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad patient population1Olanzapine LAI is designed to help support real-world adherence and improved stability, with the goal of addressing a critical treatment gap for people living with schizophrenia1Teva is committed to advancing this innovative treatment option and further build on its differentiated LAI franchise PARSIPPANY, N.J. and TEL AVIV, Israel, Dec. 09 ...

VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that James Baker will join the Company’s Technical Advisory Board (TAB), bringing more than three decades of experience in advanced materials, aerospace, defence, and graphene commercialisation. For the last 12 years, Mr. Baker led business activities related to graphene and 2D materials at the University of Manchester, including serving as Chief ...

Core Insights - Blaqclouds, Inc. has launched a new podcast studio in Colorado aimed at facilitating meaningful dialogue between emerging companies and investors, focusing on high-utility crypto projects [1][7] - The studio is equipped with advanced technology for professional-grade content creation, including multiple cameras, microphones, and mixing equipment [5][6] - Blaqclouds aims to spotlight legitimate companies and verified crypto projects, differentiating itself from hype-driven media by providing a trusted platform for credible innovation [8] Company Overview - Blaqclouds, Inc. operates in the Web3 infrastructure and development sector, bridging traditional finance with decentralized ecosystems [10] - The company’s mission is to simplify commerce and payments using blockchain technology, making crypto spending as accessible as traditional currency [10] Podcast Studio Features - The Blaqclouds Podcast Studio includes: - Three 5K cameras and three 4K cameras - Eight Shure MV7x XLR microphones - Professional video and audio mixing equipment - Dedicated guest lounge and visual integration systems [5][6] Industry Context - Denver is recognized as a leading hub for blockchain and crypto innovation, hosting significant events like ETHDenver, which enhances the ecosystem for developers and founders [6][7] - The launch of the podcast studio positions Blaqclouds at the center of this growing momentum, aiming to empower companies with visibility and tools for growth [7] Interview Request Process - Companies and crypto projects can request to be featured on the Blaqclouds Podcast through an official portal, with selection based on merit and operational legitimacy, and no fees involved [9]

Core Insights - ZenaTech, Inc. has acquired Casado Design Ltd., enhancing its Drone as a Service (DaaS) offerings in the UK and expanding into telecom infrastructure [1][2] - The acquisition aligns with the growing demand for advanced drone solutions in the telecom sector, particularly for 5G infrastructure modernization [2][3] - ZenaTech aims to leverage Casado's expertise in 3D modeling and scanning to provide safer, faster, and more cost-effective telecom infrastructure solutions [2][3] Company Overview - ZenaTech specializes in AI-driven drone solutions, DaaS, enterprise SaaS, and Quantum Computing, focusing on mission-critical business applications [5] - The company has been expanding its DaaS network through acquisitions, targeting established service companies ready for drone innovation [4][5] - ZenaTech operates globally with offices in North America, Europe, Taiwan, and the UAE, and serves various sectors including law enforcement, agriculture, and logistics [5] Industry Context - The UK telecom sector is undergoing significant transformation, driven by mergers like Vodafone–Three and substantial investments in 5G infrastructure [3] - There is a growing need for scalable, data-rich inspection and design workflows, making drone technology an attractive solution for telecom companies [3] - The trend of drone-enabled tower design and maintenance is also gaining traction across Europe, creating a favorable environment for drone-based services [3]

Core Insights - UBS AG has reduced its holding in Solar A/S, now owning 378,709 shares, which represents a 4.73% ownership stake following a sale on December 4, 2025 [1] Company Overview - Solar A/S is a leading European sourcing and services company focused on electrical, heating and plumbing, ventilation, climate, and energy solutions [2] - The company generated approximately DKK 12.2 billion in revenue in 2024 and employs around 2,900 people [3] - Solar A/S is listed on Nasdaq Copenhagen under the designation SOLAR B [3] Business Operations - The company specializes in product sourcing, value-adding services, and optimizing customer businesses [2] - Solar A/S is committed to driving efficiency improvements and providing digital tools to enhance customer success [3] - The company plays a significant role in the green transition, offering sustainable resource solutions [3]

Core Insights - Plus Therapeutics, Inc. is expanding its team at CNSide Diagnostics, LLC to enhance its capabilities in the CNS cancer diagnostics market, which is valued at over $6 billion in the U.S. [2][7] - The company is making progress towards a national launch and expanding test coverage, with plans for additional agreements with payors beyond existing contracts with UnitedHealthcare and Humana [2][8] Team Expansion - Mr. Prem Gurnani has been appointed as Senior Director of Lab Operations and Systems Implementation, bringing over 16 years of experience in diagnostics and clinical operations [8] - Ms. Elaine Luckey joins as Director of Quality and Regulatory Affairs, with over 20 years of experience in quality and regulatory affairs in laboratory environments [8] Equity Grants - The company granted stock options to Mr. Gurnani and Ms. Luckey, allowing them to purchase up to 33,750 shares each, with an exercise price equal to the closing stock price on December 4, 2025 [4][6] - Each executive also received 11,250 restricted stock units (RSUs), which will vest over three years, with one-third vesting on January 1, 2027 [5][6] Company Overview - Plus Therapeutics is a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for challenging CNS cancers, aiming to improve clinical outcomes [8][9] - The company is advancing a pipeline of product candidates, particularly in leptomeningeal metastases and recurrent glioblastoma, supported by strategic partnerships for development and manufacturing [9]